Mindfulness program aims to ease anxiety in women with heart disease
NCT ID NCT07371806
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an 8-week mindfulness program designed to reduce anxiety and improve quality of life in women with coronary artery disease. Researchers will enroll 70 women who have had CAD for at least a month and have elevated anxiety. The program includes meditation, breathing exercises, and mindfulness techniques, and will be compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mindfulness-Based Intervention Program (behavioral)
What this could lead to
If it works, this program could offer women with heart disease a simple, drug-free way to reduce anxiety and feel better day-to-day.
What could go wrong
This is a small, early-stage study with only 70 women. The results may not apply to all patients, and the program may not provide lasting benefits beyond the 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kayseri Şehir Hastanesi
Kayseri, Türki̇ye, 38000, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••